secwatch.observer — SEC 8-K summary
======================================

Issuer:     Enveric Biosciences, Inc. (ENVB)
CIK:        0000890821
Form:       8-K
Filed at:   2025-12-12T23:59:59+00:00
Accession:  0001493152-25-027541
Event type: other_material
Sentiment:  neutral
Materiality: 0.60
Item codes: 1.01, 3.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Enveric Biosciences raises $3.1M via warrant exercise inducement at $7.05 per share
--------------------------------------------------------------------------------

- Gross proceeds of ~$3.1M from cash exercise of 426,390 existing warrants at reduced price of $7.05/sh.
- Issued new Series E warrants (5-yr term) and Series F warrants (18-mo term) for up to 426,390 shares each at $7.05.
- H.C. Wainwright served as placement agent; fees of 7.0% of gross proceeds plus placement agent warrants.
- Net proceeds allocated to product development, working capital, and general corporate purposes.
- Company to file resale registration statement for new warrant shares within 10 days.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/890821/000149315225027541/0001493152-25-027541-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/890821/000149315225027541/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-25-027541

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer